Prof. Dr. med. Jan-Henning Klusmann

Prof. Dr. med. Jan-Henning Klusmann is a highly accomplished doctor specializing in pediatric and adolescent medicine, with a focus on pediatric oncology and hematology. With 16 years of experience and a list of 163 scientific publications, Dr. Klusmann has a strong background in research and clinical practice. Throughout his career, he has worked in prestigious institutions such as Children's Hospitals Boston, Harvard Medical School, and University Hospital Frankfurt am Main. One of the most notable aspects of Dr. Klusmann's career is his expertise in the molecular basis of oncogenesis in children with Down syndrome. His research in this field has earned him several awards, including the Dissertation Prize for Tumor Research and the Jan C. Molenaar Prize for Young Scientists. In addition, he has made significant contributions to the development of treatment strategies for childhood leukemia, particularly transient leukemia in neonates with Down syndrome. Dr. Klusmann's commitment to advancing pediatric oncology and hematology is further evident through his leadership roles and memberships in various professional organizations, such as the German Research Foundation and the Society for Pediatric Hematology and Oncology. He continues to contribute to the field through his work as a director at the University Hospital Frankfurt am Main, where he leads the Department of Pediatric and Adolescent Medicine. In summary, Prof. Dr. med. Jan-Henning Klusmann is a highly respected and accomplished doctor specializing in pediatric oncology and hematology. His extensive experience, research contributions, and leadership roles position him as a leading expert in the field. Through his dedication and expertise, Dr. Klusmann makes a significant impact in the treatment and understanding of pediatric cancers.